1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsDARPA-SN-26-79RFI: Realistic Mass Casualty Medical Simulation Capabilities is sponsored by DARPA Biological Technologies Office. BTO seeks input on high-fidelity, large-scale MASCAL medical simulations (50-200+ patients, <72 hours) for military/civilian use.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Contract Award Data Processing Delay Show Details) May 4, 2026 At this time, all Contract Data reports are correct as of May 2nd, 2026. We will remove this warning once the data refresh is completed. Thank You.
This processing delay impacts:Contract awards searchDatabank awards reportsSubcontract award reportingService Contract Inventory reportingBio-preferred Reporting Subcontracting Plan Reporting Contract Retrieval Issue Show Details) Apr 17, 2026 SAM. gov users of the Subcontracting Plan Reporting module, may currently experience difficulties when trying to retrieve Prime Contracts and Subcontracts within their Workspace.
We are aware of this issue and are actively working on a resolution. We appreciate your patience while we address this issue. This alert will be removed once the issue is resolved.
# Realistic Mass Casualty Medical Simulation Capabilities RFI DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) * **Contract Opportunity Type:**Special Notice (Original) * **Original Published Date:**May 15, 2026 01:37 pm EDT * **Original Response Date:**May 31, 2026 04:00 pm EDT * **Inactive Policy:**Manual * **Original Inactive Date:**Jun 01, 2026 * **Original Set Aside:** * **Product Service Code:** AC12 - NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH * 541714 - Research and Development in Biotechnology (except Nanobiotechnology) * **Place of Performance:** The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) seeks input from industry, government support organizations, military training organizations, and civilian emergency preparedness entities regarding capabilities to plan, resource, execute, and assess high-fidelity, large-scale mass casualty (MASCAL) medical simulation events.
This Request for Information (RFI) is a preliminary step to assess current capabilities to conduct realistic MASCAL simulations involving greater than 50, 100, or 200 simulated patients within a single event lasting less than 72 hours. This RFI is solely for information gathering and planning purposes. It does not constitute a solicitation for proposals, abstracts, or quotations nor indicate an intent to fund those who respond.
### Contracting Office Address * 675 NORTH RANDOLPH STREET * ARLINGTON , VA 222032114 ### Primary Point of Contact * **Dr. Jeremy Pamplin, DARPA/BTO** ### Secondary Point of Contact * **May 15, 2026 01:37 pm EDT**Special Notice (Original) What changes or improvements would you suggest?
* Freedom of Information Act * Freedom of Information Act This is a U.S. General Services Administration Federal Government computer system that is **"FOR OFFICIAL USE ONLY." ** This system is subject to monitoring. Individuals found performing unauthorized activities are subject to disciplinary action including criminal prosecution.
This system contains Controlled Unclassified Information (CUI). All individuals viewing, reproducing or disposing of this information are required to protect it in accordance with 32 CFR Part 2002 and GSA Order CIO 2103. 2 CUI Policy.
According to the current listing, eligibility includes: Open to all qualified organizations. Confirm the full requirements in the official notice before applying.
The published deadline was June 24, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
DARPA-SN-26-79RFI: Realistic Mass Casualty Medical Simulation Capabilities is funded by DARPA Biological Technologies Office. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On June 3, 2026, four DARPA Biological Technologies Office SBIR topics close simultaneously — SWiFT, BARK, EXPOSITION, and Medical Swarm Robotics. Combined Phase I plus Phase II potential exceeds $6 million per company, and together they sketch a coherent strategy of distributed, autonomous, dual-species combat casualty care that depends on small businesses, not primes, to actually build.
Read articleDPA26BZ06-DV026 offers $300,000 at Phase I or $1,800,000 as a single Direct-to-Phase-II tranche with no options. The deliverable is a simulated auction market that measures whether AI agents deceive, collude, or manipulate the humans they serve — measured entirely from the outside. Here is the 90% efficiency gate, the team composition most bidders will get wrong, and why this topic sits in DARPA's biology office.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read article